Table 3. Differentially expressed peaks between AIH and PSC bile ducts and inflammatory infiltrates.
m/z | AIH (n=14) | PSC (n=22) | Wil P | ||
---|---|---|---|---|---|
Mean | CV | Mean | CV | ||
2754 | 0.136 | 1.245 | 0.269 | 0.828 | 1.1×10−2 |
3372a | 1.954 | 1.576 | 3.968 | 0.925 | 1.2×10−2 |
3487b | 0.856 | 1.499 | 1.987 | 0.795 | 9.0×10−3 |
3588 | 0.176 | 0.716 | 0.279 | 0.724 | 1.9×10−2 |
3691 | 0.091 | 0.638 | 0.2 | 0.504 | 1.1×10−3 |
3710 | 0.116 | 1.449 | 0.228 | 0.769 | 3.3×10−3 |
4124 | 0.233 | 0.665 | 0.36 | 0.497 | 1.9×10−2 |
4749 | 0.264 | 0.825 | 0.429 | 0.526 | 1.4×10−2 |
15127c | 3.046 | 0.721 | 1.772 | 1.138 | 9.9×10−3 |
15284 | 1.837 | 0.273 | 1.392 | 0.374 | 1.9×10−2 |
Abbreviations: AIH, autoimmune hepatitis; CV, covariance; PSC, primary sclerosing cholangitis, Wil, Wilcoxon.
May represent human neutrophil defensin-2.
May represent human neutrophil defensin-3.
Hemoglobin α-chain.